Immunology 2004: Vol 112 Index

2004·2.5 MB·English

Immunology 2004 112 685-688
Author index
ADCOCK, I.M. see EYNOTT, P.R. CHUNG, F.K. see EYNOTT, P.R
AGGARWAL, R. see ROY, S. CHUNSONG, H. see SEN, Y
AGUILAR-LEON, D. see GARCIA-ROMO, G:S. CLEGG, C.H. see SIVAKUMAR, P.V
AHN, W.-S. see KIM, T.-G CONTE, M. see GENTILE, I
AL-SHANTI, N., STEWARD, C.G., GARLAND, R.J. & ROWBOTTOM., CORREIA-NEVES, M. see MACEDO, F.M
A.W. Investigation of alpha nascent polypeptide-associated complex CRAMER, D.V. see MITSUHASHI, N
functions in a human CD8° T cell ex vive expansion model using CSERNOK., E. see REINERS, K.S
antisense oligonucleotides, 397
AMANN, K. see KRAUTWALD, S DAHLGREN, C. see FU, H
ANDERSON, D.E. see REDDY. J.K. DAI, W.J.,. WALDVOGEL, A., SILES-LUCAS, M. & GOTTSTEIN. B
ANDREWS, N.C. see MACEDO, F.M. Echinococcus multilocularis proliferation in mice and respective parasite
DE ARRUDA, L.B., CHIKHLIKAR, P.R., AUGUST, J.T. & 14-3-3 gene expression is mainly controlled by an xf CD4
MARQUES, E.T.A. DNA vaccine encoding human immunodeficiency T-cell-mediated immune response, 481
virus-| Gag, targeted to the major histocompatibility complex II DALGLEISH, A.G. see VYAKARNAM, A
compartment by lysosomal-associated membrane protein, elicits DE SOUSA, M. see MACEDO, F.M
enhanced long-term memory response, 126 DEAN, G. see VORDERMEIER, M.H
ASANO, M., TAKENOUCHI-OHKUBO, N., MATSUMOTO, N.. DEJONGHE, D. see TANG, X
OGURA, Y., NOMURA, H., SUGURO, H. & MORO, I. Multiple DESOUZA, K. see SCHAEFER, T.M
cleavage sites for polymeric immunoglobulin receptor, 583 DEWITT, S. see AYUB, K
AUGER, G.A., SMITH, B.M., PEASE, J.E. & BARKER, M.D. The use of DOHERTY, M.T. see FLETCHER, H.A
membrane translocating peptides to identify sites of interaction between DRAYSON, M.T. see SOMERSET, D.A
the CSa receptor and downstream effector proteins, 590 DU, J. see YOKOYAMA, T.
AUGUST, J.T. see DE ARRUDA, L.B. ; DYUGOVSKAYA, L. see HIRSH, M
AYUB, K., LAFFAFIAN, I., DEWITT, S. & HALLETT, M.B. Ca
influx shutdown in neutrophils induced by Fas (CD95) cross-linking, 454 EASTERBROOK, P.J. see VYAKARNAM, A
EBERL, M., JOMAA, H. & HAYDAY, A.C. Integrated immune
BABIUK, L.A. see MANOJ, S responses to infection — cross-talk between human 70 T cells and
BAE, S.M. see KIM, T.-G. dendritic cells, 364
BALMELLI, C. see GUZYLACK-PIRIOU, L. ECKMANN, L. see MAASER, C
BANAPOUR, B. see REDDY, J.K. EGAN, L.J. see MAASER, C
BAOJUN, H. see SEN, Y. ELLIS, T.N. & BEAMAN, BL. Interferon-, activation of
BARKER, M.D. see AUGER, G.A. polymorphonuclear neutrophil function, 2
BATONI, G. see ESIN, S. ENGERT, A. see REINERS, K.S.
BAUERLEIN, A. see HALLER, D. ESIN, S., BATONI, G., PARDINI, M., FAVILLI, F.. BOTTAL., D..
BEAGLEY, K.W. see SCHAEFER, T.M MAISETTA, G., FLORIO, W.. VANACORE, R., WIGZELL. H. &
BEAMAN, B.L. see ELLIS, T.N. CAMPA, M. Functional characterization of human natural killer cells
BELLINGHAUSEN, I., KLOSTERMANN, B., BOTTCHER, I., responding to Mycobacterium bovis bacille Calmette-Guerin, 143
KNOP, J. & SALOGA, J. Importance of the inducible costimulator ESTRADA-GARCIA, I. see GARCIA-ROMO, G.S
molecule for the induction of allergic immune responses and its decreased EYNOTT, P.R., XU, L., BENNETT, B.L., NOBLE, A., LEUNG, S.-Y.,
expression on T helper cells after venom immunotherapy, 80 NATH, P., GRONEBERG, D.A., ADCOCK, I.M. & CHUNG, F.K
BENNETT, B.L. see EYNOTT, P.R. Effect of an inhibitor of Jun N-terminal protein kinase, SP600125
BERTELLI, E. see CHAMBERS, S.J. in single allergen challenge in sensitized rats, 446
BESRA, G:S. see LANG, G.A.
BEVEC, T. see ZAVASNIK-BERGANT, V. F AHEY, J.V. see SCHAEFER, T.M
BIRKENBACH, M.P. see MAASER, C F AVILLI, F. see ESIN. S
BOSE, M. see ROY, S. I E RNANDEZ, A.G. see LINDROTH, K
BOTTAI, D. see ESIN, S. I E RNANDEZ, C. see LINDROTH, K
BOTTCHER, I. see BELLINGHAUSEN, I i E ITERLY, B. see SOKOLOFF, A.V
BOTTO, M. see HUTCHINSON, W.L F IS CHER-LOUGHEED, J. see MITSUHASHI, N
BOWDISH, M.E. see MITSUHASHI, N F I ETCHER, H.A., OWIAFE, P., JEFFRIES, D.. HILL, P.. ROOK
BOYLE, L.H., GOODALL, J.C. & GASTON, H.J.S. Major G.A.W., ZUMLA, A., DOHERTY, M.T., BROOKES, R.H. & THE
histocompatibility complex class I-restricted alloreactive CD4 T cells, VACSEL Study Group. Increased expression of mRNA encoding
54 interleukin (IL)-4 and its splice variant IL-402 in cells from contacts of
BRENNAN, F.M. see FOEY, A.D Mycobacterium tuberculosis, in the absence of in vitro stimulation, 669
BRODE, S. & MACARY, P.A. Cross-presentation: dendritic cells and FLORES-ROMO, L. see GARCIA-ROMO, G.S
macrophages bite off more than they can chew!, 345 FLORIO, W. see ESIN, S
BROMFIELD, J.J. see JOHANSSON, M. FOEY, A.D. & BRENNAN, F.M. Conventional protein kinase C and
BROOKES, R.H. see FLETCHER, H.A. atypical protein kinase Cf differentially regulate macrophage production
BROWN, G.D. see MUKHOPADHYAY, S. of tumour necrosis factor-x and interleukin-10, 44
BYBEE, A. see GILLMORE, J.D. FORMISANO, S. see GENTILE,
BYLUND, J. see FU, H FORSTER, R. see KRAUTWALD, S
FOSTER, D.C. see SIVAKUMAR.,. P.\
CAMPA, M. see ESIN, S. FRIEDRICH, K. see MYRTEK, D
CARLOS, M.P. see REDDY, J.K. FU, H.. BYLUND. J.. KARLSSON, A., PELLME. S. & DAHLGREN, ¢
CHAE, G.-T. see KANG, T.J. The mechanism for activation of the neutrophil NADPH-oxidase by the
CHAMBERS, S.J., BERTELLI, E.. WINTERBONE, M.S., REGOLI, M.. peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs
MAN, A.L. & NICOLETTI, C. Adoptive transfer of dendritic cells from from that for interleukin-8, 201
allergic mice induces specific immunoglobulin E antibody in naive FUJIMOTO, J. see TAGUCHI, T
recipients in absence of antigen challenge without altering the FURUE, M. see ZHANG, M
T helper 1/T helper 2 balance, 72
CHANG, D.-M., SHYUE, S.-K., LIU, S.-H., CHEN, Y.-T., YEH, C.-Y., GARCIA-ROMO, G.S., PEDROZA-GONZALEZ, A., AGUILAR-
LAI, J.-H., LEE, H.-S. & CHEN, A. Dual biological functions of an LEON, D., OROZCO-ESTEVEZ, H., LAMBRECHT, B.N..,
interleukin-1 receptor antagonist—interleukin-10 fusion protein and its ESTRADA-GARCIA, I., FLORES-ROMO, L. & HERNANDEZ-
suppressive effects on joint inflammation, 643 PANDO, R. Airways infection with virulent Mycobacterium tuberculosis
CHAVEZ, R. see SOLDEVILA, G. delays the influx of dendritic cells and the expression of costimulatory
CHEN, A. see CHANG, D.-M. molecules in mediastinal lymph nodes, 661
CHEN, Y.-T. see CHANG, D.-M. GARCIA-ZEPEDA. E. see SOLDEVILA, G
CHIBA, T. see ZHANG, M. GARLAND, R.J. see AL-SHANTI, N
CHIKHLIKAR, P.R. see DE ARRUDA, L.B. GARSIDE, P. see KOBETS, N.
CHOI, I.-W. see KIM, Y.-S. GASTON, H.J.S. see BOYLE, L.I
© 2004 Blackwell Publishing Ltd
686 Author index
GENTILE, F., CONTE, M. & FORMISANO, S. Thyroglobulin as an JOBIN, C. see HALLER, D.
autoantigen: what can we learn about immunopathogenicity from the JOHANSSON, M., BROMFIELD, J.J.. JASPER, M.J. & ROBERTSON,
correlation of antigenic properties with protein structure?, 13 S.A. Semen activates the female immune response during early pregnancy
GHOSH, S.K. see LIM, S.-Y in mice, 290
GIACHINO, C. see PERFETTI. V JOHNSON, B.D. see YAN, X
GILBERT, S.C. see VORDERMEIER, M.H. JOMAA, H. see EBERL, M.
GILLMORE, J.D., HUTCHINSON, W.L., HERBERT, J., BYBEE, A.., JUNYAN, L. see SEN, Y.
MITCHELL, D.A., HASSERJIAN, R.P.. YAMAMURA, K.-L.,
SUZUKI. M., SABIN, C.A. & PEPYS, M.B. Autoimmunity and KAGNOFF. M.F. see MAASER, C.
glomerulonephritis in mice with targeted deletion of the serum amyloid KAKIUCHI, T. see TORIHATA, H.
P component gene: SAP deficiency or strain combination?, 255 KANG, J. see KHAN, M.A:S.
GOLOUH, R. see ZAVASNIK-BERGANT, V. KANG, T.J., YEUM, C.E., KIM, B.C., YOU, E.-Y. & CHAE, G.-T.
GOODALL, J.C. see BOYLE, L.H. Differential production of interleukin-10 and interleukin-12 in
GOONETILLEKE, N. see VORDERMEIER, M.H. mononuclear cells from leprosy patients with a Toll-like receptor 2
GORDON, S. see MUKHOPADHYAY, S mutation, 674
GOTTSTEIN, B. see DAI, W.J. KAPLAN, V. see HIRSH, M.
GRIEBEL, P.J. see MANOJ, S KARASUYAMA. H. see TAGUCHI, T.
GRONEBERG, D.A. see EYNOTT, P.R. KARLSSON, A. see FU, H.
GROSS, W.L. see REINERS, K.S. KATAGIRI, Y.U. see TAGUCHI, T.
GUZYLACK-PIRIOU, L., BALMELLI, C., MCCULLOUGH, K.C. & KAWAMOTO, Y. see YOKOYAMA, T.
SUMMERFIELD, A. Type-A CpG oligonucleotides activate exclusively KEARNS-JONKER, M. see MITSUHASHI, N.
porcine natural interferon-producing cells to secrete interferon-x, tumour KENNEDY. K. see KOBETS, N.
necrosis factor-x and interleukin-12, 28 KHAN, M.A.S., KANG, J. & STEINER, T.S. Enteroaggregative
Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like
HALLER, D., HOLT, L., PARLESAK, A., ZANGA, J., BAUERLEIN, receptor 5-dependent p38 MAP kinase activation, 651
A.. SARTOR, R.B. & JOBIN, C. Differential effect of immune cells on KILBY, M.D. see SOMERSET, D.A.
non-pathogenic Gram-negative bacteria-induced nuclear factor-xB KIM, B.C. see KANG, T.J.
activation and pro-inflammatory gene expression in intestinal epithelial KIM, C.-H. see KIM, T.-G.
cells, 310 KIM, D.-K. see KIM, Y.-S.
HALLETT. M.B. see AYUB, K. KIM, T.-G., KIM, C.-H., WON, E.H., BAE, S.M., AHN, W.-S., PARK,
HANSEN, H.P. see REINERS, K.S. J.-B. & SIN, J.-I. CpG-ODN-stimulated dendritic cells act as a potent
HANSEN, K.K., SAIFEDDINE, M. & HOLLENBERG, M.D. Tethered adjuvant for E7 protein delivery to induce antigen-specific antitumour
ligand-derived peptides of proteinase-activated receptor 3 (PAR3) immunity in a HPV 16 E7-associated animal tumour model, 117
activate PAR, and PAR; in Jurkat T cells, 183 KIM, Y.-S.. KWON, K.-S., KIM, D.-K., CHOI, 1.-W. & LEE, H.-K.
HARNISCH, B. see INCE, N.M. Inhibition of murine allergic airway disease by Bordetella pertussis, 624
HASSERJIAN, R.P. see GILLMORE, J.D. KIYOKAWA, N. see TAGUCHI, T.
HAYASHI, H. see YOSHINO, S KLOSTERMANN, B. see BELLINGHAUSEN, I.
HAYDAY, A.C. see EBERL, M KNOLL, M. see MYRTEK, D.
HERBERT, J. see GILLMORE, J.D. KNOP, J. see BELLINGHAUSEN, I.
HERBERT, J. see HUTCHINSON, W.L. KOBETS, N., KENNEDY, K., O.DONNELL, D. & GARSIDE, P. An
HERNANDEZ-PANDO, R. see GARCIA-ROMO, G:S. investigation of the ability of orally primed and tolerised T cells to help
HERRE, J. see MUKHOPADHYAY, S. B cells upon mucosal challenge, 550
HERRMANN. T. see KUNZMANN, V. KOS, J. see ZAVASNIK-BERGANT, V.
HEWINSON. R.G. see VORDERMEIER, M.H. KRAUSE, S. see MYRTEK, D.
HILL, A.B. see MUNKS, M.W KRAUSZ, M.M. see HIRSH, M. ;
HILL, A.V.S. see VORDERMEIER., M.H. KRAUTWALD, S., ZIEGLER, E., FORSTER, R., OHL, L.. AMANN, K.
HILL, P. see FLETCHER, H.A. & KUNZENDOREF, U. Ectopic expression of CCL19 impairs
HIMENO, K. see ZHANG. M alloimmune response in mice, 301
HIROMATSU, K. see SAKAMOTO, Y. KRETZSCHMAR, E. see KUNZMANN, V.
HIRSH, M., DYUGOVSKAYA, L., KAPLAN, V. & KRAUSZ, M.M KRUSSMANN., A. see REINERS, K.S.
Response of lung 70 T cells to experimental sepsis in mice, 153 KUNZENDORF, U. see KRAUTWALD., S.
HISAEDA. H. see ZHANG, M KUNZMANN, V., KRETZSCHMAR, E., HERRMANN, T. &
HOCHREIN, H. & WAGNER, H. Of men, mice and pigs: looking at their WILHELM, M. Polyinosinic-polycytidylic acid-mediated stimulation of
plasmacytoid dentritic cells, 26 human 76 T cells via CDI 1c dendritic cell-derived type I interferons,
HODGKIN, P.D. see TANGYE, S.G. 369
HOLLENBERG, M.D. see HANSEN, K.K. KWON, K.-S. see KIM, Y.-S.
HOLT, L. see HALLER, D
HUTCHINSON, W.L., HERBERT, J.. BOTTO, M. & PEPYS, M.B. LAFFAFIAN, I. see AYUB, K.
Classical and alternative pathway complement activation are not LAI, J.-H. see CHANG, D.-M.
required for reactive systemic AA amyloid deposition in mice, 250 LAKE, D.F. see TANG, X.
HUTCHINSON, W.L. see GILLMORE, J.D. LAMB, J.R. see JARMAN, E.R.
HUYGEN, K. see VORDERMEIER, M.H. LAMBRECHT, B.N. see GARCIA-ROMO, G:S.
LANG, G.A., MALTSEV, S.D., BESRA, G.S. & LANG, M.L.
IDZKO, M. see MYRTEK, D. Presentation of x-galactosylceramide by murine CD 1d to natural killer T
IKEDA, T. see SAKAMOTO, Y. cells is facilitated by plasma membrane glycolipid rafts, 386
INCE, N.M., HARNISCH, B., XU, Z., LEE, S.-K., LANGE, C., LANG, M.L. see LANG, G.A.
MORETTA, L., LEDERMAN, M. & LIEBERMAN, J. Increased LANGE, C. see INCE, N.M.
expression of the natural killer cell inhibitory receptor CD85j/ILT2 on JE =DERMAN, M. see INCE, N.M.
antigen-specific effector CD8 T cells and its impact on CD8 T-cell LL E SE, H.-K. see KIM, Y.-S.
function, 531 2) 3E, H.-S. see CHANG, D.-M.
INAGAKI-OHARA, K. see SAKAMOTO, Y. Jt iE, S.H, see REDDY, J.K..
ISHII, K. see ZHANG, M Li ES E, S.-K. see INCE, N.M.
ISHIKAWA, F. see TORIHATA, H. uF ZUNG, S.-Y. see EYNOTT, P.R.
ISHIWATA, K. see SAKAMOTO, Y. LJ . X. see YOSHINO, S.
IVETIC, A. & RIDLEY, A.J. Ezrin/radixin/moesin proteins and Rho LI . Y. see ZHANG, M.
GTPase signalling in leucocytes, 165 LL I CONA, I. see SOLDEVILA, G.
Lu l EBERMAN, J. see INCE, N.M.
JARMAN, E.R. & LAMB, J.R. Reversal of established CD4° type 2 LHItM , S.-Y. & GHOSH, S.K. Autoreactive responses to an environmental
T helper-mediated allergic airway inflammation and eosinophilia by factor. 2. Phthalate-induced anti-DNA specificity is downregulated by
therapeutic treatment with DNA vaccines limits progression towards autoreactive cytotoxic T cells, 94 ; :
chronic inflammation and remodelling, 631 LINDROTH, K., MASTACHE, E.F., ROOS, I., FERNANDEZ, A.G. &
JASPER, M.J. see JOHANSSON, M. FERNANDEZ, C. Understanding thymus-independent antigen-induced
JEFFRIES, D. see FLETCHER, H.A. reduction of thymus-dependent immune responses, 413
JIN, Y.-S. see MITSUHASHI, N. LINJIE, Z. see SEN, Y.
JINQUAN, T. see SEN, Y. LIU, S.-H. see CHANG, D.-M.
JIRIK, F.R. see MOODY, J.L. LOHRMANN, J. see MYRTEK, D.
© 2004 Blackwell Publishing Ltd, /mmunology, 112, 685-688
Author * index
LUDTKE, J.J. see SOKOLOFF, A.V. PARK, J.-B. see KIM, T.-G
LUTTMANN, W. see MYRTEK, D PARLESAK, A. see HALLER, D
PEAKMAN, M. see VYAKARNAM, A
MAASER, C., EGAN, L.J., BIRKENBACH, M.P., ECKMANN, L. & PEASE, J.E. see AUGER, G.A.
KAGNOFF, M.F. Expression of Epstein-Barr virus-induced gene 3 and PEDROZA-GONZALEZ, A. see GARCIA-ROMO, G.S
other interleukin-12-related molecules by human intestinal epithelium, PELLME, S. see FU, H.
437 PEPYS, M.B. see GILLMORE, J.D
MACARY, P.A. see BRODE, S. PEPYS, M.B. see HUTCHINSON, W.L
MACEDO, F.M., DE SOUSA, M., NED, R.M., MASCARENHAS, C.., PERFETTI, V.. VIGNARELLI, M.C., PALLADINI, G., NAVAZZA. \
ANDREWS, N.C. & CORREIA-NEVES, M. Transferrin is required for GIACHINO, C. & MERLINI. G. Insights into the regulation of
early T-cell differentiation, 543 immunoglobulin light chain gene rearrangements via analysis of the
MAISETTA, G. see ESIN, S. « light chain locus in 4 myeloma, 420
MALTSEV, S.D. see LANG, G.A. PUCKETT, M. see SOKOLOFF, A.V
MAN, A.L. see CHAMBERS, S.J.
MANOJ, S., GRIEBEL, P.J.. BABIUK, L.A. & VAN DRUNEN QIUPING, Z. see SEN. Y
LITTEL-VAN DEN HURK, S. Modulation of immune responses to QUN, L. see SEN, Y
bovine herpesvirus-! in cattle by immunization with a DNA
vaccine encoding glycoprotein D as a fusion protein with bovine RAMIREZ, M. see SOLDEVILA, G
CD154, 328 REDDY, J.K., BANAPOUR, B., ANDERSON, D.E.. LEE, S.H..
MARQUES, E.T.A. see DE ARRUDA, L.B. MARQUEZ, J.P... CARLOS, M.P. & TORRES, J.V. Induction of
MARQUEZ, J.P. see REDDY, J.K. immune responses against human papillomaviruses by hypervariable
MASCARENHAS, C. see MACEDO, F.M. epitope constructs, 321
MASTACHE, E.F. see LINDROTH, K REGOLI, M. see CHAMBERS, S.J
MATSUI, J. see TAGUCHI, T. REINERS, K.S., HANSEN, H.P., KRUSSMANN, A..
MATSUMOTO, N. see ASANO, M. SCHON, G., CSERNOK, E.. GROSS, W.L.,. ENGERT, A. &
MATSUO, Y. see TAGUCHI, T. VON STRANDMANN, E.P. Selective killing of B-cell hybridomas
MATTHIESEN, T. see MYRTEK, D. targeting proteinase 3, Wegener's autoantigen, 228
MCCULLOUGH, K.C. see GUZYLACK-PIRIOU, I RHODES. S.G. see VORDERMEIER, M.H
MELAMED, D. see SEAGAL, J. RICHARD, J. see TANG, X
MENCEL, R. see MITSUHASHI, N. RIDLEY, A.J. see IVETIC, A
MERLINI, G. see PERFETTI, V. ROBERTSON, S.A. see JOHANSSON, M.
MITCHELL, D.A. see GILLMORE, J.D. ROMAGNANL, S. The increased prevalence of allergy and the hygiene
MITSUHASHI, N., KEARNS-JONKER, M., WU, G.D., BOWDISH, hypothesis: missing immune deviation, reduced immune suppression, or
M.E., JIN, Y.-S.. MENCEL, R., ZAHORSKY-REEVES, J., FISCHER- both?, 352
LOUGHEED, J., WEINBERG, K.I., STARNES, V.A. & CRAMER, ROOK, G.A.W. see FLETCHER, H.A
D.V. Identification, functional analysis and expression in a heterotopic ROOS, |. see LINDROTH, K.
heart transplant model of CXCL9 in the rat, 87 ROWBOTTOM, A.W. see AL-SHANTI, N
MITTLER, R.S. see MUNKS, M.W. ROY, S.. SHARMA, S., SHARMA. M., AGGARWAL. R. & BOSE. M
MOODY, J.L. & JIRIK, F.R. Compound heterozygosity for Pten and SHIP Induction of nitric oxide release from the human alveolar epithelial
augments T-dependent humoral immune responses and cytokine cell line A549: an in vitro correlate of innate immune response to
production by CD4° T cells, 404 Mycobacterium tuberculosis, 471
MORETTA, L. see INCE, N.M.
MORI, Y. see YOSHINO. S. SABIN, C.A. see GILLMORE, J.D
MORO, I. see ASANO, M. SAI, T. see YOSHINO, S.
MOURICH, D.V. see MUNKS, M.W. SAIFEDDINE, M. see HANSEN, K.K
MUKHOPADHYAY, S., HERRE, J., BROWN, G.D. & GORDON, S. SAITO, M. see TAGUCHI, T.
The potential for Toll-like receptors to collaborate with other innate SAKAMOTO, Y., HIROMATSU, K., ISHIWATA, K., INAGAKI-
immune receptors, 521 OHARA, K., IKEDA, T.,. NAKAMURA-UCHIYAMA, F. & NAWA.,
MUNKS, M.W., MOURICH, D.V., MITTLER, R.S.. WEINBERG. Y. Chronic intestinal nematode infection induces Stat6-independent
A.D. & HILL, A.B. 4-1BB and OX40 stimulation enhance CD8 interleukin-5 production and causes eosinophilic inflammatory responses
and CD4 T-cell responses to a DNA prime, poxvirus boost in mice, 615
vaccine, 559 SALGADO, A. see SOLDEVILA, G.
MURAD, S. see VYAKARNAM, A SALOGA, J. see BELLINGHAUSEN, I
MURATA, S. see ZHANG, M. SAN, J. see SEN, Y
MYRTEK, D., KNOLL, M., MATTHIESEN, T., KRAUSE, S.., SANSOM. D.M. see SOMERSET, D.A
LOHRMANN, J., SCHILLINGER, D., IDZKO, M., VIRCHOW, C.J., SARTOR, R.B. see HALLER, D.
FRIEDRICH, K. & LUTTMANN, W. Expression of interleukin-13 SCHAEFER, T.M., DESOUZA, K., FAHEY, J.V.. BEAGLEY, K.W. &
receptor x |-subunit on peripheral blood eosinophils is regulated by WIRA, C.R. Toll-like receptor (TLR) expression and TLR-mediated
cytokines, 597 cytokine/chemokine production by human uterine epithelial
cells, 428
NAKAJIMA, H. see TAGUCHI, T. SCHILLINGER, D. see MYRTEK. D
NAKAMURA-UCHIYAMA, F. see SAKAMOTO, Y. SCHON, G. see REINERS, K.S.
NAKASHIMA, I. see YOKOYAMA, T. SCHWEIGER, A. see ZAVASNIK-BERGANT, V
NATH, P. see EYNOTT, P.R. SEAGAL, J. & MELAMED. D. Contribution of xf and y6T cells to the
NAVAZZA, V. see PERFETTI, V. generation of primary immunoglobulin G-driven autoimmune response
NAWA, Y. see SAKAMOTO, Y. in immunoglobulin-x-deficient/Ipr mice, 265
NED, R.M. see MACEDO, F.M. SEN. Y., CHUNSONG, H., BAOJUN. H., LINJIE, Z., QUN, L., SAN. J
NICOLETTI, C. see CHAMBERS, S.J. QIUPING, Z., JUNYAN, L., ZHANG, X. & JINQUAN, T. Aberration
NISHIKAWA, M. see SHAKUSHIRO, K. of CCR7° CD8~ memory T cells from patients with systemic
NOBLE, A. see EYNOTT, P.R. lupus erythematosus: an inducer of T helper type 2 bias of
NOMURA, H. see ASANO, M. CD4° T cells, 274
NORDENSSON, K. see TANG, X SHAKUSHIRO, K., YAMASAKI, Y.. NISHIKAWA, M. &
TAKAKURA, Y. Efficient scavenger receptor-mediated uptake and
O'DONNELL, D. see KOBETS, N. cross-presentation of negatively charged soluble antigens by dendritic
OBATA, C. see ZHANG, M. cells, 211
OGURA, Y. see ASANO, M. SHARMA, M. see ROY, S
OHL, L. see KRAUTWALD., S. SHARMA, S. see ROY. S
OKADA, Y. see TORIHATA, H. SHIOZAWA, Y. see TAGUCHI, T.
OKITA, H. see TAGUCHI, T. SHYUE, S.-K. see CHANG, D.-M
ONO, S.J. Professor J. Wayne Streilein, 1935-2004, 339 SIDEBOTTOM, D. see VYAKARNAM., A
ORENTAS, R.J. see YAN, X. : SILES-LUCAS, M. see DAI, W.J.
OROZCO-ESTEVEZ, H. see GARCIA-ROMO. G:S. SIN, J.-L. see KIM, T.-G
OWIAFE, P. see FLETCHER. H.A. SIVAKUMAR, P.V., FOSTER, D.C. & CLEGG, C.H. Interleukin-21 is a
T-helper cytokine that regulates humoral immunity and cell-mediated
PALLADINI, G. see PERFETTI, V. anti-tumour responses, 177
PARDINI, M. see ESIN, S. SMITH, B.M. see AUGER, G.A
© 2004 Blackwell Publishing Ltd, /mmunology, 112, 685-688
688 Author index
SOKOLOFF, A.V., PUCKETT, M., LUDTKE, J.J. & FETTERLY. B. VYAKARNAM, A., SIDEBOTTOM, D., MURAD, S., UNDERHILL,
Sequence-specific binding of normal serum immunoglobulin M to J.A., EASTERBROOK, P.J., DALGLEISH, A.G. & PEAKMAN, M.
exposed protein C-termini, 237 : Possession of human leucocyte antigen DQ6 alleles and the rate
SOLDEVILA. G., LICONA, I., SALGADO, A., RAMIREZ, M., of CD4 T-cell decline in human immunodeficiency virus-1
CHAVEZ, R. & GARCIA-ZEPEDA, E. Impaired chemokine-induced infection, 136
migration during T-cell development in the absence of Jak 3, 191
SOMERSET, D.A., ZHENG, Y., KILBY, M.D., SANSOM, D.M. & WAGNER, H. see HOCHREIN, H.
DRAYSON, M.T. Normal human pregnancy is associated with an WALDVOGEL, A. see DAI, W.J.
elevation in the immune suppressive CD25 CD4° regulatory T-cell WEINBERG, A.D. see MUNKS, M.W.
subset, 38 WEINBERG, K.I. see MITSUHASHI, N.
STARNES, V.A. see MITSUHASHI, N. WENNERAS, C. see STENFELDT, A.-L.
STEINER, T.S. see KHAN, M.A.S WIGZELL, H. see ESIN, S.
STENFELDT, A.-L. & WENNERAS, C. Danger signals derived from WILHELM, M. see KUNZMANN, V.
stressed and necrotic epithelial cells activate human eosinophils, 605 WINTERBONE, M.S. see CHAMBERS, S.J.
STEWARD, C.G. see AL-SHANTI, N WIRA, C.R. see SCHAEFER, T.M.
SUGURO, H. see ASANO, M WON, E.H. see KIM, T.-G.
SUGURO, T. see TORIHATA, H. WU, G.D. see MITSUHASHI, N.
SUMMERFIELD, A. see GUZYLACK-PIRIOU, L.
SUZUKI, H. see YOKOYAMA, T. XU, L. see EYNOTT, P.R.
SUZUKI, K. see TAGUCHI, T. XU, Z. see INCE, N.M.
SUZUKI, M. see GILLMORE, J.D.
AMAKI, K. see YOSHINO, S.
TAGUCHI, T.. KIYOKAWA, N., TAKENOUCH, H., MATSUI, J., “AMAMURA, K.-I. see GILLMORE, J.D.
TANG, W.-R., NAKAJIMA, H., SUZUKI, K., SHIOZAWA, Y.., “AMASAKI, Y. see SHAKUSHIRO, K.
SAITO, M., KATAGIRI, Y.U., TAKAHASHI, T., KARASUYAMA, "AN, X., JOHNSON, B.D. & ORENTAS, R.J. Murine CD8 lymphocyte
H., MATSUO, Y., OKITA, H. & FUJIMOTO, J. Deficiency of BLNK expansion in vitro by artificial antigen-presenting cells expressing
hampers PLC-}2 phosphorylation and Ca*~ influx induced by the CD137L (4-1BBL) is superior to CD28, and CD137L expressed
pre-B-cell receptor in human pre-B cells, 575 on neuroblastoma expands CD8 tumour-reactive effector cells
AKAHASHI, T. see TAGUCHI, 1 in vivo, 105
AKAKURA, Y. see SHAKUSHIRO, K YANAGISAWA, R. see YOSHINO, S.
AKANO, H. see YOSHINO, S YEH, C.-Y. see CHANG, D.-M.
AKENOUCH, H. see TAGUCHI, T YEUM, C.E. see KANG, T.J.
TAKENOUCHI-OHKUBO, N. see ASANO, M YOCUM, D.E. see TANG, X.
“ANAKA, K. see ZHANG, M YOKOYAMA, T., DU, J.. KAWAMOTO, Y., SUZUKI, H. &
ANAKA, Y. see TORIHATA, H NAKASHIMA, I. Inhibition of Fas-mediated apoptotic cell death of
ANEDA, S. see YOSHINO, S murine T lymphocytes in a mouse model of immunosenescence in
TANG, W.-R. see TAGUCHI, T. linkage to deterioration in cell membrane raft function, 64
ANG, X.. YOCUM., D.E., DEJONGHE, D.. NORDENSSON, K.. YOSHINO, S., YAMAKI, K., LI, X., SAT, T., YANAGISAWA, R..,
LAKE, D.F. & RICHARD, J. Increased activation-induced cell death in TAKANO, H., TANEDA, S., HAYASHI, H. & MORI, Y. Prenatal
peripheral lymphocytes of rheumatoid arthritis patients: the mechanism exposure to bisphenol A up-regulates immune responses, including
of action, 496 T helper | and T helper 2 responses, in mice, 489
TANGYE, S.G. & HODGKIN, P.D. Divide and conquer: the importance YOU, E.-Y. see KANG, T.J.
of cell division in regulating B-cell responses, 509
TORIHATA, H., ISHIKAWA, F., OKADA. Y., TANAKA, Y., UCHIDA, ZAHORSKY-REEVES, J. see MITSUHASHI, N.
T., SUGURO, T. & KAKIUCHI, T. Irradiation up-regulates CD80 ZANGA, J. see HALLER, D.
expression through two different mechanisms in spleen B cells, ZAVASNIK-BERGANT, V., SCHWEIGER, A., BEVEC, T., GOLOUH,
B lymphoma cells, and dendritic cells, 219 R., TURK, V. & KOS, J. Inhibitory p41 isoform of invariant chain and
TORRES, J.V. see REDDY, J.K its potential target enzymes cathepsins L and H in distinct populations of
TURK, V. see ZAVASNIK-BERGANT, \V macrophages in human lymph nodes, 378
ZHANG, M., ISHII, K., HISAEDA, H., MURATA, S., CHIBA, T.,
UCHIDA, T. see TORIHATA, H. TANAKA, K., LI, Y., OBATA, C., FURUE, M. & HIMENO, K.
UNDERHILL, J.A. see VYAKARNAM, A. Ubiquitin-fusion degradation pathway plays an indispensable role in
naked DNA vaccination with a chimeric gene encoding a syngeneic
VAN DRUNEN LITTEL-VAN DEN HURK, S. see MANOJ, S cytotoxic T lymphocyte epitope of melanocyte and green fluorescent
VANACORE. R. see ESIN, S. protein, 567
VIGNARELLI, M.C. see PERFETTI. V ZHANG, X. see SEN, Y.
VIRCHOW, C.J. see MYRTEK, D. ZHENG, Y. see SOMERSET, D.A.
VON STRANDMANN, E.P. see REINERS, K.S ZIEGLER, E. see KRAUTWALD, S.
VORDERMEIER, M.H., RHODES, S.G., DEAN, G.., ZUMLA., A. see FLETCHER, H.A.
GOONETILLEKE, N., HUYGEN, K., HILL, A.V.S., HEWINSON,
R.G. & GILBERT, S.C. Cellular immune responses induced in cattle by
heterologous prime—boost vaccination using recombinant viruses and
bacille Calmette-Guerin, 461
© 2004 Blackwell Publishing Ltd, Jmmunology, 112, 685-688
Immunology 2004 112 689-690
Subject index
A549, 471 CpG-oligodeoxynucleotide, 117
a NAC, 397 cross-presentation, 345
activation, 2 CFE, 53
adhesion molecules, 165 cytokine, 428, 489
adjuvants: CpG DNA, 28 cytokines, 44, 153, 404, 643, 674
adoptive transfer, 72 IL-5, 615
affinity maturation/somatic hypermutation, 413 interleukins, 2, 143, 290
z-galactosylceramide, 386 cytoskeleton, 201
allergy, 80, 624, 631 cytotoxic T cells (CTL). 105
amyloidosis, 250 cytotoxicity, 143
anergy: suppression, tolerance, 38
angiogenin, 228 danger signal, 605
animal models, 153, 624 dendritic:
in vivo, 631 cell, 72, 345, 369
studies, 28 cells, 80, 117
antibody cells in vivo, 661
repertoire, 265 cells: cross-presentation, MHC class I presentation, scavenger receptors
responses, 413, 509 211
antigen DNA
presentation, 54, 328, 378, ; vaccine, 567
processing, 345 vaccines, 328
antisense oligonucleotides, 397
anti-tumour responses, 17 Echinococcus multilocularis, 481
apoptosis: anti-Fas Ab, Fas, 64 enzymes:
asthma, 597 Jun N-terminal kinase, 446
asthma: bronchial hyperresponsiveness, inflammation, 446 proteases, proteinases, 183
autoantibodies, 13 eosinophil, 605
autoantibody, 228 eosinophils: blood, intestinal, recruitment activation, 615
autoimmune thyroid disease, 13 epithelial, 428
autoimmunity, 255, 265, 404 cells, 471
rheumatoid arthritis, human, 496 epitopes, 13
B cells, anti-DNA Epstein-Barr virus-induced gene-3, 4: 3
antibodies, | ESAT-6, 669
antibodies, autoreactive CTLs, 94 exogenous antigen, 345
Wegener's granulomatosis, 228 experimental autoimmune thyroiditis, 13
autoreactive CTLs, |
Fas /Fas-ligand, 265
B cells, 413, 509, 550, 575 fetal exposure, 489
B irradiated, LPS-stimulated, 219 food allergy, 72
bacteria: Mycobacterium bovis, 461 fusion
bacterial infection, 651 protein, 228
B-cell proteins, 643
development, 265
receptor, 575 yo
BCG, 143 T cell, 369
BHK, 583 T cells, 153
BHV-1, 328 gene expression, 310
bisphenol A, 489 GFP, 567
bovine CD154, 328 glomerulonephritis, 255
glycoprotein, 328
calcium, PARs, tyrosine phosphorylation, 183 GPCR, 201
cancer vaccines, 105 gram negative bacteria, 310
cathepsin Bacteroides vulgatus, entenc, Escherichia coli, non pathogenic, 310
H, 378
L, 378 HIV, 531
cattle, 461 HIV-1: disease progression. 136
CD8, 531 HLA Class II: genes, haplotypes. polymorphisms, 136
CD80: up-regulation, 219 human
CD8°~ T cell, 397 papilloma virus (HPV): peptides, structural proteins, virus-like particles
CD4° T cells, 5 (VLP), 321
cell papillomavirus, 117
division, 509 studies, 54
membrane: CTx-binding raft elements, Lek, 64 humans, 26
polarity, 165 humoral immunity, 17
cell-deficient mice, 481 hygiene hypothesis, 352
cell-mediated
immune response, 481] Ig secretion, 509
immunity, 177 IgE, 72
cells, 496 IgM, 237
chemokine, 191, 428 IL-10, 643
receptors: CCR7, 274 IL-4, 669
chemokines, 301, 651 IL-482, 669
monokines, 87 IL-13 receptor, 597
chemotaxis, 87, 605 IL-1, IL-10, IFN-», anti-inflammatory, 643
class switch recombination, 265 IL-12p35, 437
cleavage, 583 IL-lra-IL-10, biological function, 643
cobra venom, 250 IL-12-related molecules, 437
complement, 250, 590 immune
receptor, C5a, 590 deviation, :
costimulation, 80 suppression, 352
co-stimulatory molecules, 105 immunological memory: T-cell memory, 126
© 2004 Blackwell Publishing
690 Subject index
immunosenescence: T cells, 64 poly(I:C), 369
immunotherapy, 80, 631 priming, 201
inflammation, 44, 605, 651 proliferation, 143
inflammatory bowel disease: intestinal epithelial cells, 310 14-3-3 protein, 481
inhibitors: SP600125, 446 protein
innate delivery, 117
immune response, 471 kinase C (PKC), 44
immunity, 54 21 kinases, 651
interferon-y, 5 53 proteins: peptides, tethered ligands, VAV-1, 183
interleukin-21, |
interleukin-2 family, 779 rafts, 386
interleukin-1 receptor antagonist (IL-Ira), 643 receptor
intestinal editing, 420
epithelial cells, 437 revision, 420
epithelial cells: HT-29/MTX cells, gene expression, 310 receptors: G protein-coupled receptor, complement receptor.
inflammation: Crohn’s disease, ulcerative colitis, 310 domains (intracellular), 590
nematodes: Nippostrongylus brasiliensis, chronic infections, 615 recombinant viruses, 461
xenograft, 437 regulation of light chain rearrangement, 420
iron, 543 regulatory T cells (Treg), 38
isotype exclusion, 420 reproductive immunology, 290
isotypes /isotype switching,
sepsis, 153
Janus kinases, 19] signal
transducers: Stat6, 615
knockout, 250 transduction, 575, 651
signaling, 191
leprosy, 674 signalling, 44, 310, 575
lipid mediators, 404 G proteins, receptors, 590
lung inflammation, 153 calcium, PARs, tyrosine phosphorylation, 183
lymph signal transduction, 165
node, 378 soluble antigens: negatively charged, ovalbumin, 211
nodes, 301 surface expression, 597
lymphocyte differentiation, 509 systemic lupus erythematosus (SLE), 274
lymphocytes: autoreactive, T cells, CD14° , 496
T cells, 38, 290, 550
macrophages, 44 CD4°, 136
mCDI1d, 386 Jurkat cells, 183
mediastinal lymph nodes, 661 memory cells, Th2 cells, 274
Melanoma, 567 T lymphocytes, 404
MHC costimulation, viral, 559
class I, 54, .: 3 345 T7 phage, 237
II: trafficking, 126 targeted therapy, 228
mice, 26 T-cell
migration: traffic, 301 deficiency, 481
mononuclear cells, 674 development, 191
mouse, 250 differentiation, 543
models: PKCx transgenic mice, 64 TGF-f1, 631
models: Stat6 deficient, 615 Thi, 489
mucosal Th2, 489
immune response, 550 Th cell response, 624
immunity, 290 Th1/Th2 cells, 352
mutation, 674 thymus. 191, 543
Mycobacterium tuberculosis, 471 thyroglobulin, 13
myeloma, 420 TLR, 428
TLR-9, 26
natural TLRs, 521
antibodies, 237 Toll-like receptor 2, 674
killer cells (NK cells), 143 transcription factors: IkBx, NF-«B, signalling, 310
necrosis, 605 transferrin, 543
neutrophils, 2 receptor, 543
NF-«B, 310 transforming growth factor-f, 597
NF-«B: nuclear factors, oxidative stress, 219 transgenics: knockouts, 255
NK receptor. 531 transplantation, 87
NKT cell, 386 Treg cells, 352
NO, 471 TRP-2, 567
tuberculosis, 669
tumour immunity, 117
type I interferons, 369
UFD pathway, 567
p19, 437 uterus, 428
p28, 437
p41 invariant chain, 378 vaccination, 461]
phage display, 237 vaccine, 669
phagocytosis, 2 vaccines, 624
phagosome, 345 DNA LAMP Gag, prime/boost immunizations, 126
phosphorylation, 165 hypervariable epitope constructs (HECs), immunization, 321
plgR, 583 vaccinia virus, 583
pigs, 26 virulent Mycobacterium tuberculosis, 661
plasmacytoid dendritic cells, 26, 28
© 2004 Blackwell Publishing Ltd, Jmmunology, 112, 689